CORRECTION article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Correction: TACE-HAIC versus HAIC combined with TKIs and ICIs for hepatocellular carcinoma with a high tumor burden—a propensity-score matching comparative study
Provisionally accepted
- 1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
- 2Department of Thoracic Surgery, Tianjin Baodi Hospital, Tianjin Medical University Affiliated Baodi Hospital, Tianjin, China
- 3Central Hospital Affiliated to Shandong First Medical University, Jinan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Keywords: combination therapy, Hepatic arterial infusion chemotherapy (HAIC), Hepatocellular Carcinoma, high tumor burden, transarterial chemoembolization (TACE)
Received: 17 Dec 2025; Accepted: 18 Dec 2025.
Copyright: © 2025 Wu, Dong, Li, Shao, Wang, Wu and Chang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Huiyong Wu
Xu Chang
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.